S22-094 Chemokine Receptor Antagonist for Cancer Treatment Stanford researchers have found that a chemokine receptor antagonist can reduce immunosuppression in the tumor microenvironment and thereby delay tumor progression. Allison Banuelos Allison Zhang Kristopher Marjon Hala Berouti Irving Weissman